Aulisa was founded in 2012 by Augie Lien. The company was originally based in Palo Alto, California, at the heart of Silicon Valley. In 2013, Taiwan Aulisa Medical Devices Technologies, Inc. was established in Taipei, Taiwan, which has become the headquarters of the enterprise, responsible for all the functional areas, including product R&D, finance, accounting, manufacturing, regulatory affairs, quality systems, human resources, marketing and sales, etc.. In September of 2018, Taiwan Aulisa incorporated Aulisa Medical USA, Inc. as its wholly-own subsidiary, responsible for marketing and sales of its products in the U.S.. Aulisa integrates medical device science and information communication technologies to provide smart medical solutions for the evolving patient care landscape. The company specializes in wireless, wearable, FDA cleared vitals monitoring systems with continuous, cloud-based, patient monitoring and alarm systems. Through development of new products, Aulisa continues to focus on growing the application of Digital Health, applying big patient data analytics and AI to medical applications. Aulisa’s current line of wireless, wearable vitals monitoring systems provides continuous remote monitoring to avoid inconsistencies in spot-checking vitals and reduce the related staffing burden. The result is early detection of health incidents for adults, pediatrics and infants to improve opportunities for intervention. Incident data recording provides medical professionals with information needed to better analyze and treat patient conditions.

Augie Lien

Founder, Chairman & CEO

Augie Lien is a successful serial entrepreneur in the medical devices field. He is most recently founder, Chairman, and CEO of Taiwan Aulisa Medical Device Technologies, Inc, which develops wireless, wearable FDA cleared vitals monitoring systems for at home use as well as systems integration at the healthcare institution level. By combining medical device sciences and information communication technologies, Aulisa’s proprietary innovations address unmet needs in the medical field and technological and operational trends within the healthcare industry.

Augie’s prior start-ups include Nellcor (IPO and subsequently acquired by Medtronic), which provides patient monitoring; Menlo Care (merged with Johnson and Johnson Medical), focusing on Hospital supplies; Gynecare (IPO and then acquire by Johnson and Johnson/Ethicon), addressing Gynecology Surgery needs; and EPI (acquired by Boston Scientific), which focuses on interventional Cardiology. These start-ups have all been acquired by multi-national companies or had an IPO in the US stock market. His fifth company, Cardiva Medical, is a successful interventional cardiology company which has been acquired by Haemonetics recently in February 2021.

Augie holds an MBA from the University of Santa Clara and an MS from Stanford University. He also graduated with an MA from National Chen Chi University and a BS from National Cheng Kung University, both in Taiwan.